Direkt zum Inhalt
Merck
Alle Fotos(1)

Dokumente

1279804

USP

Fluoxetin -hydrochlorid

United States Pharmacopeia (USP) Reference Standard

Synonym(e):

(±)-N-Methyl-γ-[4-(trifluormethyl)-phenoxy]-benzolpropanamin -hydrochlorid, LY-110,140 -hydrochlorid, Prozac®

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(1)

About This Item

Empirische Formel (Hill-System):
C17H18F3NO · HCl
CAS-Nummer:
56296-78-7
Molekulargewicht:
345.79
MDL-Nummer:
MFCD00214288
UNSPSC-Code:
41116107
PubChem Substanz-ID:
329749876
NACRES:
NA.24

Qualität

pharmaceutical primary standard

API-Familie

fluoxetine

Hersteller/Markenname

USP

Anwendung(en)

pharmaceutical (small molecule)

Format

neat

SMILES String

CNCCC(C1=CC=CC=C1)OC2=CC=C(C(F)(F)F)C=C2.[H]Cl

InChI

1S/C17H18F3NO.ClH/c1-21-12-11-16(13-5-3-2-4-6-13)22-15-9-7-14(8-10-15)17(18,19)20;/h2-10,16,21H,11-12H2,1H3;1H

InChIKey

GIYXAJPCNFJEHY-UHFFFAOYSA-N

Angaben zum Gen

human ... SLC6A4(6532)

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Verwandte Kategorien

Anwendung

Fluoxetine hydrochloride USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.

Biochem./physiol. Wirkung

Selektiver Serotonin-Wiederaufnahmehemmer; Antidepressivum.

Hinweis zur Analyse

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Sonstige Hinweise

Sales restrictions may apply.

Rechtliche Hinweise

Verkauf lizenziert von Eli Lilly and Company.
Prozac is a registered trademark of Eli Lilly and Co.

Ähnliches Produkt

Produkt-Nr.
Beschreibung
Preisangaben

F0253030

Fluoxetin-Unreinheit C, European Pharmacopoeia (EP) Reference Standard

1279826

Fluoxetine Related Compound B, United States Pharmacopeia (USP) Reference Standard

1279837

Fluoxetin-verwandte Verbindung C, United States Pharmacopeia (USP) Reference Standard

1279815

Fluoxetin-verwandte Verbindung A, United States Pharmacopeia (USP) Reference Standard

BP797

Fluoxetin -hydrochlorid, British Pharmacopoeia (BP) Reference Standard

PHR1952

Fluoxetin-verwandte Verbindung A, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2041

N-Methyl-N-(3-phenylpropyl)-amin, Pharmaceutical Secondary Standard; Certified Reference Material

Y0002201

Fluoxetin Unreinheit A, CRS, European Pharmacopoeia (EP) Reference Standard

Y0002219

Fluoxetinhydrochlorid für Identifizierung und Assay, CRS, European Pharmacopoeia (EP) Reference Standard

Signalwort

Danger

Gefahreneinstufungen

Acute Tox. 4 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Eye Dam. 1 - STOT RE 2 - STOT SE 3

Zielorgane

Central nervous system

Lagerklassenschlüssel

11 - Combustible Solids

WGK

WGK 3

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable

Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Kunden haben sich ebenfalls angesehen

Slide 1 of 5

1 of 5

Paroxetin -hydrochlorid United States Pharmacopeia (USP) Reference Standard

USP

1500218

Paroxetin -hydrochlorid

Isoniazid United States Pharmacopeia (USP) Reference Standard

USP

1349706

Isoniazid

Ketanserin -tartrat ≥97%, solid

Sigma-Aldrich

S006

Ketanserin -tartrat

Arachidonylethanolamide ≥97.0% (TLC), oil

Sigma-Aldrich

A0580

Arachidonylethanolamide

Sertralin -hydrochlorid ≥98% (HPLC)

Sigma-Aldrich

S6319

Sertralin -hydrochlorid

R J Gonzalez-Rothi et al.
Chest, 107(6), 1763-1765 (1995-06-01)
We describe a patient who developed progressive dyspnea, lung infiltrates, and restrictive lung disease in association with the antidepressant fluoxetine hydrochloride (Prozac). The pathologic findings were consistent with hypersensitivity pneumonitis. An associated pulmonary phospholipidosis was also noted.
Paulina Jedynak et al.
Journal of psychiatric research, 56, 106-111 (2014-06-17)
The neurogenesis hypothesis of major depression has two main facets. One states that the illness results from decreased neurogenesis while the other claims that the very functioning of antidepressants depends on increased neurogenesis. In order to verify the latter, we
Kristie T Ota et al.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 40(3), 711-718 (2014-09-03)
Major depressive disorder (MDD) is a debilitating and widespread illness that exerts significant personal and socioeconomic consequences. Recent genetic and brain-imaging studies suggest that bicaudal C homolog 1 gene (BICC1), which codes for an RNA-binding protein, may be associated with
Sean C Godar et al.
Journal of psychiatric research, 56, 1-9 (2014-06-03)
The termination of serotonin (5-hydroxytryptamine, 5-HT) neurotransmission is regulated by its uptake by the 5-HT transporter (5-HTT), as well as its degradation by monoamine oxidase (MAO)-A. MAO-A deficiency results in a wide set of behavioral alterations, including perseverative behaviors and
Rody Kingston et al.
PLoS genetics, 17(11), e1009885-e1009885 (2021-11-05)
Molecular insights into the selective vulnerability of retinal ganglion cells (RGCs) in optic neuropathies and after ocular trauma can lead to the development of novel therapeutic strategies aimed at preserving RGCs. However, little is known about what molecular contexts determine
Alle zugehörigen Dokumente anzeigen

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.